Eagle Pharmaceuticals
EGRX
#10609
Rank
S$4.18 M
Marketcap
S$0.32
Share price
0.00%
Change (1 day)
-80.69%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: S$4.18 Million

As of April 2026 Eagle Pharmaceuticals has a market cap of S$4.18 Million. This makes Eagle Pharmaceuticals the world's 10609th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026S$4.18 M-44.17%
2025S$7.48 M-22.72%
2024S$9.68 M-89.2%
2023S$89.7 M-82.41%
2022S$0.51 B-42.63%
2021S$0.88 B10.74%
2020S$0.80 B-27.29%
2019S$1.10 B44.16%
2018S$0.76 B-28.17%
2017S$1.06 B-40.01%
2016S$1.77 B-9.39%
2015S$1.96 B582.2%
2014S$0.28 B

End of Day market cap according to different sources

On Apr 13th, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
S$4.18 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$737.00 B 17,630,967.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$376.50 B 9,006,836.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
S$1.050 T 25,136,388.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$240.14 B 5,744,742.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$151.12 B 3,615,188.93%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$150.51 B 3,600,507.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$48.22 B 1,153,567.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel